Improvement of the lymphoproliferative immune response and apoptosis inhibition upon in vitro treatment with zinc of peripheral blood mononuclear cells (PBMC) from HIV+ individuals

Clinical and Experimental Immunology

Volumn 111, Issue 2, 1998, Pages 264-268

  Neves Jr , I ^a   Bertho, A L ^a   Veloso, V G ^b   Nascimento, D V ^a   Campos Mello, D L A ^a   Morgado, M G ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Funda??o Oswaldo Cruz   (Brazil)

Author keywords

AIDS; Immunomodulation and apoptosis; Lymphoproliferative response; Mitogen; Zinc

Indexed keywords

ANTIRETROVIRUS AGENT; CD14 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; MITOGENIC AGENT; PHYTOHEMAGGLUTININ; ZINC;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; MITOGENESIS; MONONUCLEAR CELL; PRIORITY JOURNAL;

EID: 6844259887     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00495.x     Document Type: Article

References (27)

1. Willians RD, Loeb LA. Zinc requirement for DNA replication in stimulated human lymphocytes. Cell Biol 1992; 58:594-601.
2. Tapazoglou E, Prasad AS, Hill G, Brewer GJ, Kaplan J. Decreased natural killer cell activity in patients with zinc deficiency with sickle cell disease. J Lab Clin Med 1985; 105:19-22.
3. Dardenne M, Pléau JM, Savino W, Prasad AS, Bach JF. Biochemical and biological aspects of the interaction between thymulin and zinc. Prog Clin Biol Res 1993; 380:23-32.
4. Vallee BL, Falchuk KH, The biochemical basis of zinc physiology. Physiol Rev 1993; 73:70-118.
5. Dardenne M, Boukaiba N, Gagnerault MC, Homo-Delarche F, Chappuis P, Lemonneir D, Savino W. Restoration of thymus in aging mice by in vivo zinc supplementation. Clin Immunol Immunopathol 1993; 66:1-8.
6. Allen JI, Kay N, McClain C. Severe zinc deficiency in humans: association with a reversible T-lymphocyte dysfunction. Ann Intern Med 1981; 95:154-7.
7. Prasad M, Prasad AS. Nucleotides in lymphocytes of human subsets with zinc deficiency. J Lab Clin Med 1989; 114:114-9.
8. Sergio W. Zinc salts that may be effective against the AIDS virus HIV. Med Hypotheses 1988; 26:251-3.
9. Zhang ZY, Reardon IM, Hui JO et al. Zinc inhibition of renin and protease from human immunodeficiency virus type 1. Bioch 1991; 36:8717-21.
10. South TL, Blake PR, Sowder III RC, Arthur LO, Henderson LE, Summer MF. The nucleocapsid protein isolated from HIV-1 particles binds zinc and forms retroviral-type zinc finger. Bioch 1990; 29:7786-9.
11. Burke CJ, Sanyal G, Bruner MW et al. Structural implication of spectroscopic characterization of a putative zinc finger peptide from HIV-1 integrase. J Biol Chem 1992; 267:9639-44.
12. Terri LS, Blake PR, Sowder RC et al. The nucleocapsid protein isolated from HIV-1 particles binds zinc and forms retroviral-type zinc fingers. Biochem 1990; 29:7786-9.
13. Falutz J, Tsoukas C, Gold P. Zinc as a cofactor in human immunodeficiency virus-induced immunosuppression. JAMA 1988; 259:2850-1.
14. Fabris N, Mocchegiani G, Gall M, Jrato L, Lazzarin A, Moron M. AIDS, zinc deficiency and thymic hormone failure. JAMA 1988; 259:839-40.
15. Niel MHG, Soresen D, Odaka N et al. Relationship of serum copper and zinc levels to HIV-1 seropositivity and progressions to AIDS. Acq Immun Defic Syndr 1991; 4:976-80.
16. Meyaard L, Otto SA, Jonker RR, Minjter MJ, Keel RPM, Miedema F. Programmed death of T cells in HIV-1 infection. Sci 1992; 257:217-9.
17. Telford WG, King LE, Fraker PJ. Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Prolif 1991; 24:447-59.
18. Gougeon ML, Oliver R, Garcia S, Guetard D, Dragtic T, Dauguet C, Montaigner L. Evidence for an engagement process towards apoptosis in lymphocytes of HIV-1 infected patients. C R Acad Sci Paris 1991; T.312: série III, 529-37.
19. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992; 175:331-40.
20. Ameisen JC, Capron A. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol Today 1991; 12:102-5.
21. th Int Conf on AIDS Berlin, 1993; PO-B28-2150:493.
22. Caselli M, Bicocchi R. Taux sérique du zinc chez les malades atteints du syndrome d'immunodéfficit acquis. La Presse Médicale 1993; 37:1877.
23. Tanaka Y, Shiozawa S, Morimoto I, Fujita I. Role of zinc in interleukin-2 (IL-2) mediated T cell activation. Scan J Immunol 1992; 31:547-52.
24. Malavé I, Rodriguez J, Araujo Z, Rojas I. Effect of zinc on the proliferative response of human lymphocytes: mechanism of its mitogenic action. Immunopharmacol 1990; 20:1-10.
25. Prasad AS, Beck FWJ, Endre L, Handschu W, Kukuruga M, Kumar G. Zinc deficiency affects cells cycle and deoxithymidine kinase gene-expression in HUT-78 cells. J Lab Clin Med 1996; 128:51-60.
26. Gougeon ML, Montagnier L. Apoptosis in AIDS. Sci 1993; 260:1269-70.
27. Li CJ, Friedman DJ, Wang C, Metelev V, Pardee AB. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Sci 1995; 268:429-31.